[go: up one dir, main page]

NO971519L - Process for the preparation of antigenically potentiated enteric agents and vaccines containing them - Google Patents

Process for the preparation of antigenically potentiated enteric agents and vaccines containing them

Info

Publication number
NO971519L
NO971519L NO971519A NO971519A NO971519L NO 971519 L NO971519 L NO 971519L NO 971519 A NO971519 A NO 971519A NO 971519 A NO971519 A NO 971519A NO 971519 L NO971519 L NO 971519L
Authority
NO
Norway
Prior art keywords
antigenically
potentiated
preparation
vaccines containing
enteric agents
Prior art date
Application number
NO971519A
Other languages
Norwegian (no)
Other versions
NO971519D0 (en
Inventor
John L Pace
Steven M Frey
Original Assignee
Microcarb Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/538,545 external-priority patent/US5679564A/en
Application filed by Microcarb Inc filed Critical Microcarb Inc
Publication of NO971519D0 publication Critical patent/NO971519D0/en
Publication of NO971519L publication Critical patent/NO971519L/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/105Delta proteobacteriales, e.g. Lawsonia; Epsilon proteobacteriales, e.g. campylobacter, helicobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/09Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/107Vibrio
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/04Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
    • C12Q1/045Culture media therefor
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18Testing for antimicrobial activity of a material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55555Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Toxicology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO971519A 1994-10-05 1997-04-03 Process for the preparation of antigenically potentiated enteric agents and vaccines containing them NO971519L (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US31840994A 1994-10-05 1994-10-05
US08/538,545 US5679564A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic campylobacter bacteria and vaccines
US08/538,543 US5681736A (en) 1994-10-05 1995-10-03 Methods for producing enhanced antigenic shigella bacteria and vaccines comprising same
PCT/US1995/013196 WO1996011258A1 (en) 1994-10-05 1995-10-04 Methods for producing enhanced antigenic enteric bacteria and vaccines comprising same

Publications (2)

Publication Number Publication Date
NO971519D0 NO971519D0 (en) 1997-04-03
NO971519L true NO971519L (en) 1997-05-27

Family

ID=27405987

Family Applications (1)

Application Number Title Priority Date Filing Date
NO971519A NO971519L (en) 1994-10-05 1997-04-03 Process for the preparation of antigenically potentiated enteric agents and vaccines containing them

Country Status (16)

Country Link
EP (1) EP0804542A4 (en)
JP (1) JP3394047B2 (en)
CN (1) CN1168693A (en)
AU (1) AU704283B2 (en)
BR (1) BR9509276A (en)
CA (1) CA2202027A1 (en)
CZ (1) CZ104397A3 (en)
FI (1) FI971403L (en)
HU (1) HUT77876A (en)
IL (1) IL115521A0 (en)
MX (1) MX9702431A (en)
NO (1) NO971519L (en)
NZ (1) NZ295907A (en)
PL (1) PL182700B1 (en)
SG (2) SG73509A1 (en)
WO (1) WO1996011258A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69534635T2 (en) * 1994-10-05 2006-09-21 Emergent Immunosolutions Inc. PROCESS FOR PRODUCTION OF REINFORCED ANTIGENING HELIOBACTER SP. AND VACCINE THOSE INCLUDE
EP2327720A1 (en) * 2003-05-30 2011-06-01 Intercell AG Enterococcus antigens
US20100074846A1 (en) * 2006-03-17 2010-03-25 Ellis John A Campylobacter Vaccines and Methods of use
EP2161035B1 (en) * 2007-05-28 2019-08-21 Daiichi Sankyo Company, Limited Bordetella parapertussis-containing whole-cell vaccine composition
CN107513553B (en) * 2017-09-18 2021-05-18 江南大学 Method for screening lactobacillus with antagonistic campylobacter jejuni infection function
CN109633151B (en) * 2018-12-26 2022-03-11 西北农林科技大学 A kind of Salmonella Enteritidis detection method, test strip and application
US12403187B2 (en) 2018-12-31 2025-09-02 Bellevacc As Bacterial vaccine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06503231A (en) * 1991-09-18 1994-04-14 アムジエン・インコーポレーテツド Hepatitis B vaccine formulation containing bile salts

Also Published As

Publication number Publication date
CN1168693A (en) 1997-12-24
EP0804542A4 (en) 1998-10-28
NZ295907A (en) 1999-04-29
CA2202027A1 (en) 1996-04-18
HUT77876A (en) 1998-09-28
EP0804542A1 (en) 1997-11-05
MX9702431A (en) 1998-05-31
JP3394047B2 (en) 2003-04-07
IL115521A0 (en) 1996-06-18
FI971403A7 (en) 1997-06-04
NO971519D0 (en) 1997-04-03
BR9509276A (en) 1997-11-18
SG73509A1 (en) 2000-06-20
JPH10507347A (en) 1998-07-21
AU704283B2 (en) 1999-04-15
FI971403A0 (en) 1997-04-04
CZ104397A3 (en) 1998-06-17
PL182700B1 (en) 2002-02-28
WO1996011258A1 (en) 1996-04-18
PL319580A1 (en) 1997-08-18
FI971403L (en) 1997-06-04
AU3956195A (en) 1996-05-02
SG73510A1 (en) 2000-06-20

Similar Documents

Publication Publication Date Title
NO20002835D0 (en) 2-aryl-oxodihydropurine derivatives, process for the preparation of these medicinal preparations containing them, and intermediates therefor
DK0622408T3 (en) Composition and process for the preparation of gelatin-free soft capsules
DK0815130T3 (en) Casein phosphopeptide, casein containing the same and method of preparation thereof
NO962179D0 (en) Process for the preparation of metallocene and its use
NO965103D0 (en) Bicyclic aromatic compounds, pharmaceutical and cosmetic preparations containing them and their use
NO975987D0 (en) 4-Phenylaminothiazole derivatives, process for their preparation and pharmaceutical compositions containing said derivatives
NO971680D0 (en) Antifoam mixture and process for its preparation
FI971268A7 (en) Process for the preparation of 1,3-alkanediols and 3-hydroxyaldehydes
NO20012963L (en) Process for the preparation of 3-alkanoylindoles and 3-alkylindoles
NO914665D0 (en) PROCEDURE FOR THE REMOVAL OF TRIAL CYLASSINES AND SORCTION MATERIALS FOR CARRYING OUT THE PROCEDURE
FI941447A0 (en) Oral preparations of ubidikarenone in the form of capsules
EP0475023A3 (en) Curable mixtures for the preparation of epoxy-networks, method for their preparation and their application
FI955708L (en) Method for the preparation and isolation of 2-phenyl-3-aminopiperidine
NO971519L (en) Process for the preparation of antigenically potentiated enteric agents and vaccines containing them
FI961378A0 (en) Process for the preparation of N-methyl-3- (1-methyl-4-piperidinyl) -14-indole-5-ethanesulfonamide
NO930796D0 (en) GLYCOPEPTY DERIVATIVES, PROCEDURE FOR THEIR PREPARATION AND PHARMACEUTICAL AGENTS CONTAINING THESE
NO975634D0 (en) Stable pharmaceutical preparations containing tiludronate hydrates and process for the preparation of pharmaceutical preparations
NO972023D0 (en) Benzisoxazole derivatives and pesticide preparations containing these
NO304110B1 (en) Process for the preparation of glutardialdehyde
FI971402A7 (en) Method for the preparation of enhanced antigenic Helicobacter species and vaccines containing them
FI971267A7 (en) Process for the preparation of 1,3-alkanediols and 3-hydroxyaldehydes
NO960766D0 (en) New protein and process for its preparation
NO307080B1 (en) Process for the preparation of catalysts and their use
FI964410A7 (en) Process for the preparation of 4-amino-delta4-3-ketosteroids via 4-nitro-delta4-3-ketosteroids
NO971419L (en) Process for Preparation of 1,3-Alkenediols and 3-Hydroxyaldehydes

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application